פריוריקס טטרה

Country: Israel

Language: Hebrew

Source: Ministry of Health

Active ingredient:

LIVE ATTENUATED MEASLES VIRUS; LIVE ATTENUATED MUMPS VIRUS; LIVE ATTENUATED RUBELLA VIRUS; LIVE ATTENUATED VARICELLA VIRUS

Available from:

GLAXO SMITH KLINE (ISRAEL) LTD

ATC code:

J07BD54

Pharmaceutical form:

אבקה וממס להכנת תמיסה להזרקה

Composition:

LIVE ATTENUATED MEASLES VIRUS 10^ 3.0 CCID50; LIVE ATTENUATED MUMPS VIRUS 10^ 4.4 CCID50; LIVE ATTENUATED RUBELLA VIRUS 10^ 3.0 CCID50; LIVE ATTENUATED VARICELLA VIRUS 10^ 3.3 PFU

Administration route:

תת-עורי

Prescription type:

מרשם נדרש

Manufactured by:

GLAXO SMITH KLINE BIOLOGICALS S.A

Therapeutic group:

MEASLES, COMBINATIONS WITH MUMPS, RUBELLA AND VARICELLA, LIVE ATTENUATED

Therapeutic area:

MEASLES, COMBINATIONS WITH MUMPS, RUBELLA AND VARICELLA, LIVE ATTENUATED

Therapeutic indications:

Priorix-Tetra is indicated for active immunisation against measles, mumps, rubella and varicella in children from the age of 12 months up and including 12 years of age.

Authorization date:

2023-07-31